IMBA - Institute of Molecular Biotechnology
Scientific, Molecular & Cellular Biology
A team of researchers, spearheaded by the Gerlich lab at IMBA, has uncovered how cells remove unwanted components from the nucleus following mitosis.…
Scientific, General News
HCA|Organoid is a new EU research project that combines single-cell profiling and organoid technology to validate organoids as faithful models of…
Technology
The new start-up QUANTRO Therapeutics at the Vienna BioCenter uses innovative transcriptome profiling technologies in a novel drug discovery pipeline…
Stem Cell Biology
The establishment of self-organizing heart organoids called cardioids, at IMBA – Institute of Molecular Biotechnology of the Austrian Academy of…
General News
An important pillar in the fight against the Covid-19 pandemic is accurate, rapid and frequent testing for the coronavirus SARS-CoV-2, for example,…
On Thursday a special visit to the IMBA and the Vienna Open Lab presented the most important cornerstones of the new Research Funding Act. Anton…
Ines Méhu-Blantar
Senior Communications Manager
+43 1 79044 - 3628
Send E-Mail
Caterina Purini
Communications Manager
+43 1 79044 - 4405
RT @TrainingVbc: Our VIP2 three-year postdoctoral fellowship program in the Life Sciences is now open for applications, check our website f… read more
RT @NeuroStemMod: Today is the day!!!!! Neuro Stem Modulation SFB Virtual SYMPOSIUM! Cool neuroscience talks - Poster presentation - Netw… read more
RT @TrainingVbc: The Vienna BioCenter PhD Program has 17 open positions in the summer call which has just opened for applications. Check o… read more
Awards & Honors
Jürgen Knoblich, Scientific Director of IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – is now part of the Board of…
Disease Mechanisms, Molecular & Cellular Biology
An international team of researchers with the participation of IMBA - Institute of Molecular Biotechnology of the Austrian Academy of Sciences -…
Scientific, Stem Cell Biology, Molecular & Cellular Biology, Technology
IMBA is part of the MAD-CoV 2 project and is funded with 1.1 Million Euros by the European Commission for developing antivirals against SARS-CoV-2.
Page 3 of 32.
We use cookies to adapt the website to your needs and to offer special features to you. By using our website, you agree to it.
Further information on cookies can be found in our privacy policy.
Click on „Cookie-Preferences“ to change the cookie settings manually.
